Neoantigen Based Personalized Cancer Therapeutic Vaccines Market | Size, Share, Growth

Neoantigen Based Personalized Cancer Therapeutic Vaccines Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - March

Report Code: VMR-18306

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Neoantigen Based Personalized Cancer Therapeutic Vaccines Market (2025-2030)

Neoantigen-based personalized cancer therapeutic vaccines represent a groundbreaking advancement in oncology, leveraging tumor-specific neoantigens to activate the immune system against cancer cells. These vaccines are tailored to an individual’s tumor mutation profile, enhancing specificity and reducing off-target effects. By utilizing next-generation sequencing and bioinformatics, these therapies offer a precise and highly personalized approach to cancer treatment, distinguishing them from conventional immunotherapies

Disruptive Impact and Opportunities:

The market for neoantigen-based personalized cancer therapeutic vaccines is poised to disrupt the oncology landscape by introducing an innovative, patient-specific treatment modality. The emergence of these vaccines simplifies therapeutic approaches through customization, making them a novel and targeted option. They enhance treatment safety by reducing autoimmune responses and increasing efficacy through a highly individualized strategy. The growing advancements in bioinformatics, AI-driven neoantigen identification, and improvements in vaccine delivery platforms create a significant commercial opportunity in this expanding field. As clinical trials continue to validate their effectiveness, the demand for personalized cancer vaccines is expected to grow, offering substantial investment potential for biopharmaceutical companies and healthcare providers.

Emerging Drugs:

Tedopi (OSE2101)
NEO-PV-01
GEN-009
TG01 Vaccine
iNeo-Vac-P01
NEO-PV-01

Marketed Drugs:

None

Companies:

Gradalis
OSE Immunotherapeutics
Immunitor
Gristone Oncology
Genocea
Targovax
Hangzhou Neoantigen Therapeutics
Neon Therapeutics

Market Segmentation:

By Type

DNA-Based Neoantigen Vaccines
RNA-Based Neoantigen Vaccines
Peptide-Based Neoantigen Vaccines
Dendritic Cell-Based Neoantigen Vaccines
Viral Vector-Based Neoantigen Vaccines
Others

By Administration Type

Intravenous (IV)
Intradermal
Subcutaneous
Intramuscular
Others

What’s in It for You?

Provides insights into pipeline advancements and emerging technologies in personalized cancer immunotherapy
Identifies key market players and potential strategic partnerships
Assesses clinical trial progress and regulatory pathways for market entry
Evaluates competitive positioning and investment opportunities
Highlights growth potential and commercial feasibility in precision oncology

Neoantigen Based Personalized Cancer Therapeutic Vaccines - Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2025 & 2030: By Key Country (10MM)
  2. Global Market Size 2025 & 2030: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900